Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | BRD2 | P25440 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | MITF | O75030 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28320461 | 1.00 | LMNA (0.59) | LMNAKMT2ACYP1A2CYP2D6CYP2C9 | |
| Water SCHEMBL6288346 | 0.98 | LMNA (0.57) | LMNAKMT2ACYP1A2CYP2D6CYP2C9 | |
| SCHEMBL28172900 | 0.98 | LMNA (0.57) | LMNAKMT2ACYP1A2CYP2D6CYP2C9 | |
| Water SCHEMBL6344864 | 0.98 | LMNA (0.57) | LMNAKMT2ACYP1A2CYP2D6CYP2C9 | |
| SCHEMBL59155 | 0.98 | — | — | |
| SCHEMBL10871994 | 0.95 | LMNA (0.59) | LMNAKMT2ACYP1A2CYP2D6CYP2C9 | |
| SCHEMBL1857819 | 0.95 | LMNA (0.59) | LMNAKMT2ACYP1A2CYP2D6CYP2C9 | |
| SCHEMBL2297517 | 0.95 | LMNA (0.59) | LMNAKMT2ACYP1A2CYP2D6CYP2C9 | |
| SCHEMBL839318 | 0.95 | LMNA (0.59) | LMNAKMT2ACYP1A2CYP2D6CYP2C9 | |
| SCHEMBL3620504 | 0.95 | LMNA (0.59) | LMNAKMT2ACYP1A2CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1299 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108441-A1 | PRESERVATIVE SYSTEM | L'OREAL (FR) | 2026-04-23 | — | — | US | claimed |
| EP-4262528-B1 | DEVICE AND METHOD FOR CONTINUOUS EVEN APPLICATION OF COMPOSITION TO SKIN | KENVUE BRANDS LLC (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4588522-B1 | COMPOSITION FOR TREATMENT AND/OR PREVENTION OF A CORONA VIRUS INFECTION | DR KURT WOLFF GMBH & CO KG (DE) | 2026-01-21 | — | — | EP | claimed |
| US-20250361442-A1 | ETCHANT COMPOSITION | DONGJIN SEMICHEM CO LTD (KR) | 2025-11-27 | — | — | US | claimed |
| EP-3490680-B1 | TOPICAL COSMETIC COMPOSITION FOR RESTRUCTURING AND PROTECTING HAIR AND SCALP, AND USES THEREOF | KEMON S P A (IT) | 2025-11-19 | — | — | EP | claimed |
| EP-4588522-A2 | COMPOSITION FOR TREATMENT AND/OR PREVENTION OF A CORONA VIRUS INFECTION | Dr. Kurt Wolff GmbH & Co. KG (DE) | 2025-07-23 | — | — | EP | claimed |
| EP-4304738-B1 | COMPOSITION FOR TREATMENT AND/OR PREVENTION OF A CORONA VIRUS INFECTION | DR KURT WOLFF GMBH & CO KG (DE) | 2025-06-18 | — | — | EP | claimed |
| US-12303576-B2 | Two phase water-based smudge-resistant make-up remover | L'OREAL (FR) | 2025-05-20 | — | — | US | claimed |
| CN-222808372-U | Post-treatment device for zinc pyrrolidone carboxylate | 湖州欧利生物科技有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-119868179-A | Anti-dandruff oil-control anti-hair-loss shampoo containing hinokitiol and preparation method thereof | 广州恒广复合材料有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-1646151-A | Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis | SINCLAIR PHARMACEUTICALS LTD (GB) | 2005-07-27 | — | — | CN | claimed |
| US-20050019288-A1 | Alcohol-based aerosol deodorant composition comprising at lease one zinc salicylate or a derivative thereof | L'OREAL S.A. (FR) | 2005-01-27 | — | — | US | claimed |
| US-20040110650-A1 | Method for maximizing scalp health and inducing enhanced visual and tactile hair quality | SHAKLEE CORPORATION | 2004-06-10 | — | — | US | claimed |
| WO-2004010958-A2 | A METHOD FOR MAXIMIZING SCALP HEALTH AND INDUCING ENHANCED VISUAL AND TACTILE HAIR QUALITY | SHAKLEE CORPORATION (US) | 2004-02-05 | — | — | WO | claimed |
| US-6632421-B2 | In the form of an emulsion | L'OREAL (FR) | 2003-10-14 | — | — | US | claimed |
| US-20020127193-A1 | Deodorant composition comprising a water-soluble zinc salt as odour-absorbing agent | L'OREAL (FR) | 2002-09-12 | — | — | US | claimed |
| US-6346238-B1 | WATER IN SILICONE EMULSIONS, WATER SOLUBLE ZINC SALT TO ABSORB ODOR AND WATER FOR EMULSIONS | L'OREAL (FR) | 2002-02-12 | — | — | US | claimed |
| CN-1077426-C | Deodorant composition comprising water-soluble zinc salt as odor absorber | OREAL (FR) | 2002-01-09 | — | — | CN | claimed |
| EP-0768080-B1 | Deodorant composition containing a hydrosoluble zinc salt as odour absorbing agent | OREAL (FR) | 1998-06-24 | — | — | EP | claimed |
| CN-1169111-A | Deodorant composition comprising a water-soluble zinc salt as odor absorbing agent | OREAL (FR) | 1997-12-31 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020127193-A1 | Deodorant composition comprising a water-soluble zinc salt as odour-absorbing agent | SLC30A6, SLC39A3, DDT | LMNA 4554/4885KMT2A 3760/4885CYP1A2 4113/4885 |
| US-20050019288-A1 | Alcohol-based aerosol deodorant composition comprising at lease one zinc salicylate or a derivative thereof | ADH5, ADH1A, ADH1C | LMNA 2839/4885KMT2A 3693/4885CYP1A2 819/4885 |
| US-20260108441-A1 | PRESERVATIVE SYSTEM | CUTA, TRPA1, S100A9 | LMNA 580/4885KMT2A 2081/4885CYP1A2 2714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.